Three triple quads achieve a new global standard in mass spectrometry - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Three triple quads achieve a new global standard in mass spectrometry

The triple quadrupole mass spectrometers LCMS-8030, LCMS-8040 and GCMS-TQ8030 complete Shimadzu’s UFMS series consisting of seven powerful systems. The UFMS product family provides higher sensitivity, greater excellence in data quality, increased analytical throughput and a wider range of applications.

GCMS-TQ8030 — ultra-fast analysis meets sensitivity and accuracy
The GCMS-TQ8030 achieves the highest sensitivity in its class for multiple reaction monitoring (MRM) measurements based on UFsweeper® technology.  Superior mass spectra and sensitivity at high scan speeds of up to 20,000 masses/sec is achieved using Advanced Scanning Speed Protocol (ASSP™).

The GCMS-TQ8030’s ecology mode reduces carbon dioxide emissions through a reduction of power consumption in analysis standby mode of 36 percent while also decreasing the consumption of carrier gas.

LCMS-8030 – features the most innovative technology found in a commercial tandem quadrupole mass analyzer. The system combines the power of triple quadrupole mass spectrometry with unmatched speed to provide the ideal complement to its UHPLC systems. The LCMS-8030 accelerates workflows for high-throughput analysis.

The LCMS-8030 features ultra-fast multiple reaction monitoring (MRM) transitions, enabling data acquisition with up to 500 different channels per second. The improvements to the electronics provide ultra-fast mass spectrum measurement speeds of 15,000 u/sec without sacrificing sensitivity or resolution, with ultra-fast polarity switching (15 msec) for maximum information without signal deterioration.

LCMS-8040 – Expanded range of ultra-fast, high-sensitivity applications
The system combines newly improved ion optics and collision cell technology with proprietary ultrafast technologies. This significantly expands the application range and ensures high-sensitivity, high-throughput analysis at lower levels of detection.

The LCMS-8040 is the world’s fastest LCMS/MS tandem mass spectrometer and provides multiple reaction monitoring (MRM) transition speeds of up to 555 MRMs/sec second. This is based on UFsweeper® II collision cell technology that maintains sensitivity and suppresses cross-talk, even for high-speed or simultaneous multi-component analyses.

For more information please visit www.shimadzu.eu

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
9%
All of the above.
41%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
FindPharma Custom Search

Click here